HAYWARD, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM - News) today announced the initial public offering of 6,000,000 shares of common stock at a price of $7.00 per share. Thermage has granted the underwriters an option to purchase up to an additional 900,000 shares at the initial public offering price to cover over-allotments, if any. The common stock will trade on the Nasdaq Global Market under the symbol “THRM.”
Merrill Lynch & Co. is the bookrunning manager for the offering. Thomas Weisel Partners LLC, Wachovia Securities, C.E. Unterberg Towbin and Maxim Group LLC are co-managers.
A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy the common stock of Thermage, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Copies of the final prospectus may be obtained from the offices of Merrill Lynch & Co., 101 California Street, Suite 1400, San Francisco, CA 94111, Thomas Weisel Partners LLC, One Montgomery Street, San Francisco, CA 94104, Wachovia Securities, Four Embarcadero Center, 9th Floor, San Francisco, CA 94111, C.E. Unterberg Towbin, 350 Madison Avenue, New York, NY 10017, and Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174.
About Thermage
Located in Hayward, Calif., Thermage, Inc. is a medical device company dedicated to the development of innovative capacitive radiofrequency technologies. Its science and technology provide a non-invasive procedure to reduce wrinkles and tighten skin.
Source: Thermage, Inc.
